Sirona Biochem Corp Cash Flow-to-Debt Ratio
Sirona Biochem Corp cash flow-to-debt ratio. Sirona Biochem Corp (SBM) has a Cash Flow-to-Debt Ratio of -0.13x as of July 2024, meaning its operating cash flow of CA$-552.59K could theoretically repay 0% of its total liabilities (CA$4.27 Million) in one year. Check earnings quality score of Sirona Biochem Corp to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sirona Biochem Corp (2011–2023)
Cash flow-to-debt ratio of Sirona Biochem Corp from 2011 to 2023. Historical debt coverage capacity for Sirona Biochem Corp across 13 annual periods. Check Sirona Biochem Corp cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sirona Biochem Corp Cash Flow-to-Debt Ratio by Year (2011–2023)
Sirona Biochem Corp cash flow-to-debt ratio by year from 2011 to 2023. Year-by-year debt coverage analysis for Sirona Biochem Corp. For the full cash flow conversion analysis, see SBM cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.50x | CA$-1.76 Million | CA$3.54 Million | ▲ +75.5% |
| 2022 | -2.02x | CA$-2.18 Million | CA$1.08 Million | ▼ -29.8% |
| 2021 | -1.56x | CA$-2.16 Million | CA$1.38 Million | ▼ -54.2% |
| 2020 | -1.01x | CA$-2.11 Million | CA$2.09 Million | ▲ +41.3% |
| 2019 | -1.72x | CA$-3.56 Million | CA$2.07 Million | ▼ -779.7% |
| 2018 | -0.20x | CA$-593.35K | CA$3.03 Million | ▲ +74.2% |
| 2017 | -0.76x | CA$-2.50 Million | CA$3.29 Million | ▲ +43.6% |
| 2016 | -1.35x | CA$-2.10 Million | CA$1.56 Million | ▲ +12.0% |
| 2015 | -1.53x | CA$-3.06 Million | CA$2.00 Million | ▼ -34.8% |
| 2014 | -1.14x | CA$-1.86 Million | CA$1.64 Million | ▲ +45.6% |
| 2013 | -2.09x | CA$-2.50 Million | CA$1.20 Million | ▲ +4.9% |
| 2012 | -2.20x | CA$-2.15 Million | CA$976.91K | ▲ +36.7% |
| 2011 | -3.47x | CA$-2.54 Million | CA$732.20K | — |